-The World Bank WASHINGTON: The number of people living on less than $1.25 per day has decreased dramatically in the past three decades, from half the citizens in the developing world in 1981 to 21 percent in 2010, despite a 59 percent increase in the developing world population. However, a new analysis of extreme poverty released today by the World Bank shows that there are still 1.2 billion people living in...

-The Hindu     This demographic potential offers India and its economy an unprecedented edge Every third person in an Indian city today is a youth. In about seven years, the median individual in India will be 29 years, very likely a city-dweller, making it the youngest country in the world. India is set to experience a dynamic transformation as the population burden of the past turns into a demographic dividend, but the benefits...

-The Hindu Around 72 villages from Maharashtra's Raigad district have started a sit-in demonstration in front of the tehsil office in Mangaon against the multi-billion-dollar ambitious Delhi-Mumbai Industrial Corridor (DMIC). . The villagers who began the agitation on Wednesday will hold dharna against the acquisition of 67,000 acres of land from these 72 villages. Each village will submit its letter of opposition to the project in the government office during the dharna...

-The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned. An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon...

-The Hindu The Supreme Court has denied Novartis a patent for its anti-cancer drug Gleevec. This leaves the door open for Indian pharmaceutical companies to produce their own versions of the drug. Since these are sold at roughly one tenth of the patented brand price, for thousands of cancer patients it means the difference between medicine and no medicine at all. It is not just cancer patients that will benefit, but...